We are live on ! Find out more
MLICM

Metropolitan Life Insurance Company (MetLife) Portfolio holdings

AUM $357M
1-Year Est. Return 13.97%
This Fund
S&P 500
This Quarter Est. Return
+0.3%
1 Year Est. Return
+13.97%
3 Year Est. Return
+50.79%
5 Year Est. Return
+74.78%
10 Year Est. Return
+368.42%
AUM
$13.9B
AUM Growth
-$512M
Cap. Flow
-$427M
Cap. Flow %
-3.07%
Top 10 Hldgs %
13.98%
Holding
2,837
New
70
Increased
591
Reduced
1,041
Closed
180

Sector Composition

Rank Sector Weight
1 Technology 13.38%
2 Financials 12.91%
3 Healthcare 12.18%
4 Energy 11.84%
5 Industrials 10.16%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SCSC icon
1426
Scansource
SCSC
$1.07B
$786K 0.01%
22,732
RGR icon
1427
Sturm, Ruger & Co
RGR
$599M
$783K 0.01%
16,084
AIR icon
1428
AAR Corp
AIR
$5.87B
$782K 0.01%
32,364
-143
-0.4% -$3.88K
HCA icon
1429
HCA Healthcare
HCA
$87.8B
$782K 0.01%
11,083
+213
+2% +$14.1K
HRI icon
1430
Herc Holdings
HRI
$5.76B
$780K 0.01%
10,237
-77
-0.7% -$6.58K
BPFH
1431
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
$780K 0.01%
62,918
-748
-1% -$9.43K
CSR
1432
Centerspace
CSR
$945M
$779K 0.01%
10,116
+43
+0.4% +$3.61K
NVAX icon
1433
Novavax
NVAX
$1.31B
$778K 0.01%
9,325
+1,532
+20% +$138K
ROG icon
1434
Rogers Corp
ROG
$2.52B
$778K 0.01%
14,213
CCMP
1435
DELISTED
CMC Materials, Inc. Common Stock
CCMP
$778K 0.01%
18,765
-967
-5% -$41.2K
TUMI
1436
DELISTED
TUMI HLDGS INC COM
TUMI
$777K 0.01%
38,203
ABMD
1437
DELISTED
Abiomed Inc
ABMD
$776K 0.01%
31,234
ACHN
1438
DELISTED
Achillion Pharmaceuticals
ACHN
$776K 0.01%
77,798
-848
-1% -$7.87K
AEGR
1439
DELISTED
Aegerion Pharmaceuticals
AEGR
$776K 0.01%
23,233
OSG
1440
Octave Specialty Group
OSG
$214M
$773K 0.01%
34,955
LTXB
1441
DELISTED
LegacyTexas Financial Group Inc
LTXB
$771K 0.01%
32,192
LCII icon
1442
LCI Industries
LCII
$2.56B
$769K 0.01%
18,224
ECOL
1443
DELISTED
US Ecology, Inc.
ECOL
$768K 0.01%
16,424
NTUS
1444
DELISTED
Natus Medical Inc
NTUS
$767K 0.01%
25,987
MTGE
1445
DELISTED
MTGE Investment Corp. Common Stock
MTGE
$767K 0.01%
40,780
ARCB icon
1446
ArcBest
ARCB
$3.25B
$766K 0.01%
20,528
+1,112
+6% +$42.2K
CONE
1447
DELISTED
CyrusOne Inc Common Stock
CONE
$765K 0.01%
31,831
+8,283
+35% +$211K
UTIW
1448
DELISTED
UTI WORLDWIDE INC
UTIW
$765K 0.01%
71,987
AIN icon
1449
Albany International
AIN
$1.83B
$762K 0.01%
22,397
CATO icon
1450
Cato Corp
CATO
$67.7M
$759K 0.01%
22,016
-802
-4% -$26.7K

Similar funds

Metropolitan Life Insurance Company (MetLife)'s Q3 2014 Portfolio in Review

As of Q3 2014, Metropolitan Life Insurance Company (MetLife) held 2,837 positions worth $13.9B, down 3.6% from $14.4B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Metropolitan Life Insurance Company (MetLife) withdrew a net $427M in Q3 2014, closing 180 positions and reducing 1,041 holdings. Its most notable exit was Accenture, an estimated $31.6M position sold in full.

By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Metropolitan Life Insurance Company (MetLife) opened a new position in Monsanto Co worth $35.2M.

  • Metropolitan Life Insurance Company (MetLife)'s largest Q3 2014 buy was Monsanto Co: 313,199 shares worth $35.2M.
  • Metropolitan Life Insurance Company (MetLife) added most to Microsoft in Q3 2014, an estimated $14M increase.
  • Metropolitan Life Insurance Company (MetLife)'s biggest Q3 2014 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $22.5M.
  • Metropolitan Life Insurance Company (MetLife) fully exited Accenture in Q3 2014, selling an estimated $31.6M.
  • Metropolitan Life Insurance Company (MetLife)'s ten largest holdings make up 14% of its $13.9B portfolio in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife) opened 70 new positions and closed 180 in Q3 2014.
  • Metropolitan Life Insurance Company (MetLife)'s portfolio value fell 3.6% quarter-over-quarter to $13.9B.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q3 2014, filed 10 Nov 2014.